METTL14 expression was found to be decreased in colorectal cancer patients, and Mettl14 knockdown in vitro resulted in decreased m6A deposition on downstream target Xist, a long non-coding RNA (lncRNA) that has been found to promote proliferation (Yang et al., 2020). The gene discussed is METTL14; the disease is colorectal cancer.